Kheiron Medical Technologies
Deploys deep learning to assist radiologists in detecting early-stage breast cancer.
What they do
Kheiron Medical Technologies develops Mia, an artificial intelligence platform designed to support radiologists in breast cancer screening. The software analyzes digital mammograms to act as an independent second reader, improving early detection rates while reducing workloads for clinical imaging teams.
The record
- Vertical
- Oncology
- Sub-segment
- AI-powered radiology diagnostics
- Product type
- Software as a medical device
- Stage
- Series A
- Headquarters
- London, United Kingdom
- Region
- Europe
- Founded
- 2016
- Total funding
- $22M raised
Notable investors: Atomico, Greycroft, Connect Ventures, Hoxton Ventures.